Operating Lease, Payments in USD of Dare Bioscience, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Dare Bioscience, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q3 2025.
  • Dare Bioscience, Inc. Operating Lease, Payments for the quarter ending September 30, 2025 was $165K, a 2.93% increase year-over-year.
  • Dare Bioscience, Inc. Operating Lease, Payments for the twelve months ending September 30, 2025 was $615K, a 9.24% increase year-over-year.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2024 was $600K, a 50% increase from 2023.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2023 was $400K, a 33.3% increase from 2022.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2022 was $300K, a 35.1% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Dare Bioscience, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $615K $165K +$4.7K +2.93% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $610K $164K +$5K +3.15% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $605K $164K +$5K +3.15% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $600K $122K +$37.3K +44.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $563K $160K +$54.7K +51.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 $508K $159K +$54K +51.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $454K $159K +$54K +51.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $400K $84.5K +$68.5K +428% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $332K $106K +$24.5K +30.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $307K $105K +$25K +31.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $282K $105K -$18K -14.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $300K $16K -$103K -86.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $403K $81K -$36K -30.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $439K $80K -$34K -29.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $473K $123K +$11K +9.82% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $462K $119K +$7K +6.25% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $455K $117K +$6K +5.41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $449K $114K +$4K +3.64% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $445K $112K -$16K -12.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $461K $112K +$40K +55.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-30
Q3 2020 $421K $111K +$83K +296% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $338K $110K +$83K +307% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $255K $128K +$101K +374% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $154K $72K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-27
Q3 2019 $28K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $27K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $27K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14

Dare Bioscience, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $600K +$200K +50% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $400K +$100K +33.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $300K -$162K -35.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $462K +$1K +0.22% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $461K +$307K +199% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-30
2019 $154K Jan 1, 2019 Dec 31, 2019 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.